{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-016218","form_type":"8-K","ticker":"TNON","cik":"0001560293","company_name":"Tenon Medical, Inc.","filed_at":"2024-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.610867+00:00","generated_at":"2026-06-05T19:14:50.348684+00:00","sec_items":["1.01","1.02","3.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Tenon Medical raises $2.6M gross in Series A Preferred, retires $1.25M debt","bullets":["Gross proceeds of ~$2.6M from sale of 172,239 Series A Preferred shares at $15.125/unit and 258,374 warrants.","Exchanged $1.25M secured notes plus accrued interest for 84,729 Preferred shares and 157,094 warrants, fully repaying the notes.","Preferred Stock convertible at $1.5125/share; warrants exercisable at $1.2705/share with 5-year term.","Proceeds allocated to growth investments, working capital, and general corporate purposes.","No dividends on Series A; voting capped at 9.99%; anti-dilution provision requires stockholder approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-016218","json":"https://secwatch.observer/filing/0001213900-24-016218.json","markdown":"https://secwatch.observer/filing/0001213900-24-016218.md","text":"https://secwatch.observer/filing/0001213900-24-016218.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1560293/000121390024016218/0001213900-24-016218-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1560293/000121390024016218/ea0200461-8k_tenonmed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T19:14:50.348684+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"91f4b7930180ae2235f66332fedc79d2c8db4f5d","claim":"Tenon Medical, Inc. entered into Securities Purchase Agreement with certain investors valued at $2,605,000 (effective 2024-02-20).","evidence_excerpt":"On February 20, 2024 (the “Closing Date”), Tenon Medical, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain investors (the “Investors”), pursuant to which the Company agreed to sell, issue and deliver to the Investors, in a private placement offering (the “Offering”), a total of 172,239 shares of the Company’s Series A Preferred Stock (the “Series A Preferred Stock”) and warrants (the “Warrants”) to purchase 258,374 shares of common stock, par value $0.001 per share, of the Company (“Common Stock”) at an exercise price equal to $1.2705 per share for an aggregate offering price of $2,605,000.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1560293/000121390024016218/0001213900-24-016218-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain investors"},{"label":"Value","value":"$2,605,000"},{"label":"Effective","value":"2024-02-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}